Physician profile
Adam W Range
NPI 1457869018
$4,809.81
in general payments reported to CMS, 2019-2025
17 companies · $597 in 2025
The $597 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2022: $2,429 · 2023: $384 · 2024: $999 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856 · Travel and Lodging: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.71 |
| Travel and Lodging | $124.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,403.33 | 2022 | |
| Abbvie INC. | $840.14 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $781.42 | 2021-2022 | |
| Nalu Medical, INC. | $419.69 | 2025 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $229.82 | 2021-2022 | |
| Pfizer INC. | $186.99 | 2024 | |
| Smith+Nephew, INC. | $143.74 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico |
| Davol INC. | $125.78 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $123.55 | 2023 | Fasenra |
| Alexion Pharmaceuticals, INC. | $120.06 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $117.92 | 2022 | |
| Biogen, INC. | $96.51 | 2022 | |
| Depuy Synthes Sales INC. | $76.63 | 2022-2024 | Monovisc |
| Bioventus LLC | $58.46 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Goode Surgical INC | $54.28 | 2024-2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $17.21 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Teva Pharmaceuticals USA, INC. | $14.28 | 2024 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Range listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.